← Back to Search

Intensive Multidisciplinary Feeding Intervention (IMFI) for Eating Disorders

N/A
Waitlist Available
Led By Valerie Volket, PhD, BCBA-D
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights

Summary

This trial will study if it's feasible to quickly wean people with ARFID off of enteral feedings, and if doing so has any effect when used as part of an intensive multidisciplinary feeding intervention.

Eligible Conditions
  • Eating Disorders
  • Feeding Disorders
  • Avoidant Restrictive Food Intake Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Percentage of oral intake
Percent of patients achieving full wean and time to full wean
Secondary outcome measures
Change in weight and BMI
Mealtime performance.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intensive Multidisciplinary Intervention (Standard Care) + Hunger provocation (Rapid Tube Wean)Experimental Treatment1 Intervention
Children with a history of chronic food refusal will be randomized to receive the experimental arm that combines standard care with rapid tube wean. All schedules and documents will be updated accordingly. After the 50% tube wean cut, the dietitian will use regular tube wean sheet to provide credit for oral intake for remainder of admission.
Group II: Intensive Multidisciplinary Intervention (Standard Care)Active Control1 Intervention
Children with a history of chronic food refusal will be randomized to receive the standard of care. The standard of care for tube wean is to accomplish the balance between enteral supplementation and oral intake, the tube feeding regimen will follow the schedule of therapeutic meals (e.g., mid-day supplementation occurs after morning therapeutic meals).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intensive Multidisciplinary Feeding Intervention (IMFI) standard of care + rapid tube weaning
2021
N/A
~20

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,655 Previous Clinical Trials
2,572,467 Total Patients Enrolled
Children's Healthcare of AtlantaOTHER
165 Previous Clinical Trials
105,114 Total Patients Enrolled
Valerie Volket, PhD, BCBA-DPrincipal InvestigatorEmory -Children's Ped Institute

Media Library

Intensive Multidisciplinary Feeding Intervention (IMFI)-Standard of Care Clinical Trial Eligibility Overview. Trial Name: NCT05053438 — N/A
Eating Disorders Research Study Groups: Intensive Multidisciplinary Intervention (Standard Care), Intensive Multidisciplinary Intervention (Standard Care) + Hunger provocation (Rapid Tube Wean)
Eating Disorders Clinical Trial 2023: Intensive Multidisciplinary Feeding Intervention (IMFI)-Standard of Care Highlights & Side Effects. Trial Name: NCT05053438 — N/A
Intensive Multidisciplinary Feeding Intervention (IMFI)-Standard of Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT05053438 — N/A
~4 spots leftby Jul 2025